DCGI has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults.
from Latest News https://www.dnaindia.com/india/report-covid-vaccine-news-sii-s-covovax-approved-as-heterologous-booster-dose-for-adults-3017466
Monday, January 16, 2023
Home »
Latest News
,
News
» Covid vaccine news: SII's Covovax approved as heterologous booster dose for adults
0 comments:
Post a Comment